Suppr超能文献

血清缺氧诱导因子-1α、胰岛素样生长因子-1和胰岛素样生长因子结合蛋白-3与早期肝细胞癌患者的复发及总生存期相关。

Serum HIF-1α, IGF-1 and IGFBP-3 correlate to recurrence and overall survival in early-stage hepatocellular carcinoma patients.

作者信息

Ding Shujun, Ding Wei, Zhang Ye, Chen Yunbao, Tang Hongtao, Jiang Xiao, Chen Jun

机构信息

Department of Ultrasonography, Wuxi People's Hospital Affiliated to Nanjing Medical University, Qingyang Road, Wuxi, 214023, Jiangsu, China.

Department of Interventional Radiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Qingyang Road, Wuxi, 214023, Jiangsu, China.

出版信息

Biomark Med. 2024;18(23):1027-1036. doi: 10.1080/17520363.2024.2421149. Epub 2024 Nov 18.

Abstract

Recurrence of hepatocellular carcinoma (HCC) after ultrasound-guided microwave ablation (UGMWA) was a critical issue. Therefore, it is significant to identify the role of hypoxia-inducible factor 1 α (HIF-1α), insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in recurrence. HCC patients receiving UGMWA were divided into recurrence and no-recurrence groups. The preoperative and postoperative risk factors were compared between these two groups. Preoperative and postoperative serum levels of HIF-1α, IGF-1 and IGFBP-3 were closely associated with the recurrence of HCC. Serum HIF-1α level was increased, while serum levels of IGF-1 and IGFBP-3 were decreased in HCC patients with recurrence. HIF-1α, IGF-1 and IGFBP-3 were associated with and predicted the recurrence of HCC after UGMWA, respectively or in combination.

摘要

超声引导下微波消融(UGMWA)后肝细胞癌(HCC)的复发是一个关键问题。因此,明确缺氧诱导因子1α(HIF-1α)、胰岛素样生长因子-1(IGF-1)和IGF结合蛋白-3(IGFBP-3)在复发中的作用具有重要意义。接受UGMWA的HCC患者被分为复发组和无复发组。比较这两组患者术前和术后的危险因素。术前和术后血清中HIF-1α、IGF-1和IGFBP-3水平与HCC复发密切相关。复发的HCC患者血清HIF-1α水平升高,而血清IGF-1和IGFBP-3水平降低。HIF-1α、IGF-1和IGFBP-3分别或联合与UGMWA后HCC的复发相关并可预测复发。

相似文献

1
Serum HIF-1α, IGF-1 and IGFBP-3 correlate to recurrence and overall survival in early-stage hepatocellular carcinoma patients.
Biomark Med. 2024;18(23):1027-1036. doi: 10.1080/17520363.2024.2421149. Epub 2024 Nov 18.

本文引用的文献

1
Ultrasound-guided microwave ablation in the treatment of early-stage tongue cancer.
Front Oncol. 2022 Aug 30;12:950228. doi: 10.3389/fonc.2022.950228. eCollection 2022.
3
Independent prognostic value of HIF-1α expression in radiofrequency ablation of lung cancer.
Oncol Lett. 2020 Jan;19(1):849-857. doi: 10.3892/ol.2019.11130. Epub 2019 Nov 21.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Trajectories of plasma IGF-1, IGFBP-3, and their ratio in the Mayo Clinic Study of Aging.
Exp Gerontol. 2018 Jun;106:67-73. doi: 10.1016/j.exger.2018.02.015. Epub 2018 Feb 21.
7
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations.
J Hepatol. 2018 Apr;68(4):783-797. doi: 10.1016/j.jhep.2017.10.004. Epub 2017 Oct 13.
8
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
World J Gastroenterol. 2017 Aug 7;23(29):5282-5294. doi: 10.3748/wjg.v23.i29.5282.
10
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
Gastroenterology. 2017 Mar;152(4):745-761. doi: 10.1053/j.gastro.2016.11.048. Epub 2016 Dec 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验